Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma

JOURNAL ARTICLE published December 2019 in Journal for ImmunoTherapy of Cancer

Research funded by National Cancer Institute/National Institutes of Health (CRADA between NCI and EMD Serono)

Authors: Arun Rajan | Christopher R. Heery | Anish Thomas | Andrew L. Mammen | Susan Perry | Geraldine O’Sullivan Coyne | Udayan Guha | Arlene Berman | Eva Szabo | Ravi A. Madan | Leomar Y. Ballester | Stefania Pittaluga | Renee N. Donahue | Yo-Ting Tsai | Lauren M. Lepone | Kevin Chin | Fiona Ginty | Anup Sood | Stephen M. Hewitt | Jeffrey Schlom | Raffit Hassan | James L. Gulley